Emulsion-based adjuvants for influenza vaccines
- 1 April 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 8 (4) , 483-492
- https://doi.org/10.1586/erv.09.5
Abstract
(2009). Emulsion-based adjuvants for influenza vaccines. Expert Review of Vaccines: Vol. 8, No. 4, pp. 483-492. doi: 10.1586/erv.09.5Keywords
This publication has 46 references indexed in Scilit:
- An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy AdultsThe Journal of Infectious Diseases, 2008
- Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor SignallingPLoS Pathogens, 2008
- Molecular and cellular signatures of human vaccine adjuvantsProceedings of the National Academy of Sciences, 2008
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trialVaccine, 2008
- Vaccination of Macaques with Adjuvanted Formalin-Inactivated Influenza A Virus (H5N1) Vaccines: Protection against H5N1 Challenge without Disease EnhancementJournal of Virology, 2008
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza VaccinePLOS ONE, 2008
- Ab and T cell epitopes of influenza A virus, knowledge and opportunitiesProceedings of the National Academy of Sciences, 2007
- Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against SqualeneClinical and Vaccine Immunology, 2006
- Translating Innate Immunity into Immunological Memory: Implications for Vaccine DevelopmentPublished by Elsevier ,2006
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humansPublished by Elsevier ,2001